Hidradenitis Suppurativa and Obesity
Obesity is one of the most common and significant comorbidities associated with Hidradenitis Suppurativa (HS). Understanding the complex biological relationship between excess body weight and HS inflammation is crucial for effective, comprehensive management of both conditions.
Why are HS and Obesity Linked?
The connection between HS and obesity is not merely coincidental; it is deeply rooted in shared biological pathways. Obesity creates a state of chronic, low-grade systemic inflammation, which can trigger or worsen the inflammatory processes of HS. Additionally, excess adipose (fat) tissue alters hormone levels, particularly androgens, which play a role in follicular occlusion. Physically, increased skin folds create areas of friction and moisture, providing an ideal environment for HS lesions to develop. It is important to remember that obesity does not "cause" HS in isolation, but it is a powerful exacerbating factor.
The Biological Connection
Research has identified several key mechanisms that explain how excess body weight influences the development and severity of Hidradenitis Suppurativa.
Systemic Inflammation
Adipose (fat) tissue is not just for energy storage; it is an active endocrine organ that secretes pro-inflammatory cytokines, such as TNF-alpha and IL-6. This creates a state of chronic "meta-inflammation" throughout the body, which primes the immune system to overreact, fueling the inflammatory lesions characteristic of HS.
Hormonal Imbalance
Obesity is frequently associated with insulin resistance and hyperinsulinemia. High insulin levels can stimulate the ovaries and adrenal glands to produce more androgens (male hormones). Elevated androgens can increase keratin production and alter sebum in hair follicles, leading to the blockages that initiate HS flares.
Mechanical Friction
Higher body weight often results in deeper and more numerous skin folds (intertriginous areas). These areas experience increased mechanical friction, heat, and moisture. This physical stress on the skin can damage hair follicles, making them more susceptible to rupture and subsequent inflammation, a key step in HS pathogenesis.
Management Strategies for HS and Obesity
Addressing both HS and obesity simultaneously can lead to significant improvements in quality of life. A multidisciplinary approach is often the most effective strategy.
| Strategy | Impact on Obesity | Impact on HS |
|---|---|---|
| Dietary Modifications | Promotes sustainable weight loss and improves metabolic health. | Anti-inflammatory diets can reduce systemic inflammation and potentially decrease flare frequency. |
| GLP-1 Agonists (e.g., Semaglutide) | Highly effective for significant weight loss and improving insulin sensitivity. | Emerging evidence suggests these medications may directly reduce HS inflammation and improve symptoms. |
| Bariatric Surgery | Provides substantial, long-term weight loss for severe obesity. | Studies show significant remission or improvement of HS symptoms following surgery-induced weight loss. |
| Biologic Therapies (e.g., Adalimumab) | No direct effect on weight loss; dosing may need adjustment based on BMI. | Effectively targets specific inflammatory pathways (like TNF-alpha) to control moderate-to-severe HS. |
When to Seek Comprehensive Care
Managing HS alongside obesity requires careful monitoring. You should consult your healthcare team if you experience any of the following:
Worsening HS Flares: An increase in the frequency, size, or pain of HS lesions, especially in skin folds.
Signs of Metabolic Syndrome: Symptoms such as increased thirst, frequent urination, fatigue, or high blood pressure readings.
Difficulty with Mobility: When HS pain or excess weight significantly limits your ability to perform daily activities or exercise.
Mental Health Concerns: Experiencing symptoms of depression, anxiety, or severe distress related to body image and chronic pain.
Care Coordination
Effective management often involves a team approach. Your dermatologist can manage the skin manifestations of HS, while a primary care physician, endocrinologist, or weight management specialist can assist with obesity and metabolic health. A registered dietitian can provide tailored nutritional guidance.
Frequently Asked Questions
Related Comorbidities
HS and Diabetes
Explore the link between HS, insulin resistance, and type 2 diabetes.
HS and PCOS
Understand how hormonal imbalances connect HS and Polycystic Ovary Syndrome.
HS and Sleep Apnea
Learn about the association between HS, obesity, and obstructive sleep apnea.
Take Control of Your Health
Managing HS and weight can be challenging, but you don't have to do it alone. Explore treatment options and connect with healthcare professionals who understand both conditions.
References
- Kjærsgaard Andersen R, Riis PT, Zachariae C, et al. Hidradenitis suppurativa and smoking, obesity, psoriasis, inflammatory bowel disease, and systemic sclerosis: results from a 2-sample Mendelian randomization study. JAMA Dermatol. 2025. doi:10.1001/jamadermatol.2025.5010
- Mintoff D, Borg I, Pace NP. Obesity and hidradenitis suppurativa: targeting meta-inflammation for therapeutic gain. Clin Exp Dermatol. 2023;48(10):1103-1111. doi:10.1093/ced/llad182
- Raudonis T, et al. Demographic Data, Risk Factors, and Disease Burden of HS. J Clin Med. 2024;13(18):5521. doi:10.3390/jcm13185521
- Balgobind A, et al. Association between obesity and hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol. 2020;83(1):191-193. doi:10.1016/j.jaad.2019.12.066
- Kromann CB, Ibler KS, Kristiansen VB, Jemec GB. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol. 2014;94(5):553-557. doi:10.2340/00015555-1800
Content reviewed for medical accuracy. Always consult a qualified healthcare provider.